相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
Marcin Kortylewski et al.
CANCER CELL (2009)
gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
Julia Bollrath et al.
CANCER CELL (2009)
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Heehyoung Lee et al.
CANCER CELL (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy
Marcin Kortylewski et al.
CANCER RESEARCH (2009)
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway
Lin Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Role of Stat3 in suppressing anti-tumor immunity
Marcin Kortylewski et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Accessing the therapeutic potential of immunostimulatory nucleic acids
Winfried Barchet et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice
Maciej Kujawski et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Synthetic oligonucleotides as modulators of inflammation
Dennis Klinman et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
Hendrik Poeck et al.
NATURE MEDICINE (2008)
Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies
D. E. Spaner et al.
ONCOGENE (2008)
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
A. M. Krieg
ONCOGENE (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Transvascular delivery of small interfering RNA to the central nervous system
Priti Kumar et al.
NATURE (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Holger Kanzler et al.
NATURE MEDICINE (2007)
Humoral immunity, inflammation and cancer
Ting-Ting Tan et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?
Jack D. Bui et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling
Ranmal Samarasinghe et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins
Jack D. Bui et al.
CANCER RESEARCH (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
M Kortylewski et al.
NATURE MEDICINE (2005)
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque
BJ Li et al.
NATURE MEDICINE (2005)
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing
TP Chendrimada et al.
NATURE (2005)
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
EW Song et al.
NATURE BIOTECHNOLOGY (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
DH Kim et al.
NATURE BIOTECHNOLOGY (2005)
Functional polarity is introduced by Dicer processing of short substrate RNAs
SD Rose et al.
NUCLEIC ACIDS RESEARCH (2005)
Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis
TX Xie et al.
ONCOGENE (2004)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
E Latz et al.
NATURE IMMUNOLOGY (2004)
Shifting foci of hematopoiesis during reconstitution from single stem cells
YA Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
TH Wang et al.
NATURE MEDICINE (2004)
Use of CpG oligodeoxynucleotides as immune adjuvants
DM Klinman et al.
IMMUNOLOGICAL REVIEWS (2004)
STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: A critical role of STAT3 in innate immunity
T Welte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
A Toll-like receptor recognizes bacterial DNA
H Hemmi et al.
NATURE (2000)
Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression
EM Benkhart et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
